Decreased PTEN expression and increased AKT expression correlate with the progression of high-degree NSCLC in clinical settings, indicating that PTEN/AKT signaling may serve as an indicator for NSCLC diagnosis or progression analysis. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.